Zoomex has expanded its derivatives lineup by launching twelve new USDT-margined stock perpetual contracts, offering 24/7 long and short exposure to major U.S. equities without traditional market hours.
The new contracts cover UnitedHealth Group (UNH), General Electric (GE), JPMorgan Chase (JPM), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Amgen (AMGN), Walmart (WMT), Coca-Cola (KO), PepsiCo (PEP), Mastercard (MA), PayPal Holdings (PYPL), and Berkshire Hathaway Class B (BRK.B).
Most pairs offer up to 25x leverage, while Regeneron and PayPal are capped at 20x. All contracts settle in USDT, support cross and isolated margin, feature funding every eight hours, and carry a funding rate cap of 2.00%, or 2.50% for Regeneron. Traders can access them under the Stock category in Zoomex's derivatives and futures page.
The launch comes as tokenized stock perpetuals have become one of the fastest-growing corners of crypto derivatives in 2026. Zoomex says its Fair Access and Rule-Based Execution approach publishes leverage caps, tick sizes, and funding rate ceilings upfront.
Founded in 2021, Zoomex serves more than 3 million users across over 35 countries and regions and offers more than 700 trading pairs. The platform holds registrations including U.S. MSB, Canada MSB, U.S. NFA, and Australia AUSTRAC, and has completed security audits with Hacken.
The announcement was distributed as sponsored content, and the platform encourages traders to review current contract specifications before opening positions.
